"Metribolone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic non-aromatizable androgen and anabolic steroid. It binds strongly to the androgen receptor and has therefore also been used as an affinity label for this receptor in the prostate and in prostatic tumors.
Descriptor ID |
D015741
|
MeSH Number(s) |
D04.210.500.365.415.550
|
Concept/Terms |
Metribolone- Metribolone
- 17 beta-Hydroxy-17 alpha-methylestra-4,9,11-trien-3-one
- Methyltrienolone
R-1881- R-1881
- R 1881
- R1881
- Ru-1881
- Ru 1881
- Ru1881
|
Below are MeSH descriptors whose meaning is more general than "Metribolone".
Below are MeSH descriptors whose meaning is more specific than "Metribolone".
This graph shows the total number of publications written about "Metribolone" by people in this website by year, and whether "Metribolone" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Metribolone" by people in Profiles.
-
Glucocorticoid receptor activity contributes to resistance to androgen-targeted therapy in prostate cancer. Horm Cancer. 2014 Apr; 5(2):72-89.
-
Low-calcium serum-free defined medium selects for growth of normal prostatic epithelial stem cells. Cancer Res. 2006 Sep 01; 66(17):8598-607.
-
Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells. Br J Cancer. 2006 Aug 21; 95(4):485-95.
-
Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells. Br J Cancer. 2002 Nov 18; 87(11):1321-7.
-
Estrogen and progestin receptors and aromatase activity in rhesus monkey prostate. Endocrinology. 1988 Nov; 123(5):2312-22.